Sudeep Pharma Board Meeting on Aug 4 to Approve Q1 FY27 Results

Sudeep Pharma Ltd has announced that its Board of Directors will convene on August 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. In line with SEBI regulations, the company has closed its trading window from July 1, 2026, and it will reopen 48 hours after the financial results are declared, extending until August 6, 2026. This meeting is a routine procedural step for financial reporting.